Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Change in Receivables (2020 - 2025)

Privia Health (PRVA) has 6 years of Change in Receivables data on record, last reported at -$139.9 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 42.2% year-over-year to -$139.9 million; the TTM value through Dec 2025 reached $36.7 million, up 84.97%, while the annual FY2025 figure was $36.7 million, 84.97% up from the prior year.
  • Change in Receivables reached -$139.9 million in Q4 2025 per PRVA's latest filing, down from $55.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $72.5 million in Q1 2025 and bottomed at -$139.9 million in Q4 2025.
  • Average Change in Receivables over 5 years is $12.0 million, with a median of $29.2 million recorded in 2022.
  • The widest YoY moves for Change in Receivables: up 369.38% in 2022, down 469.04% in 2022.
  • A 5-year view of Change in Receivables shows it stood at $15.4 million in 2021, then plummeted by 469.04% to -$56.7 million in 2022, then decreased by 4.58% to -$59.3 million in 2023, then plummeted by 65.76% to -$98.4 million in 2024, then crashed by 42.2% to -$139.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$139.9 million in Q4 2025, $55.0 million in Q3 2025, and $48.9 million in Q2 2025.